Raymond G Cavalcante
Overview
Explore the profile of Raymond G Cavalcante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
366
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao Y, Cavalcante R, Waller J, Deng F, Scruggs A, Huang Y, et al.
Clin Epigenetics
. 2024 Oct;
16(1):139.
PMID: 39380119
Background: DNA methylation plays a critical role in asthma development, but differences in DNA methylation among adults with varying asthma severity are less well-defined. Objective: To examine how DNA methylomic...
2.
Gonzalez M, Brophy B, Eido A, Leonetti A, Djomehri S, Augimeri G, et al.
Cancer Res
. 2024 Jul;
84(19):3235-3249.
PMID: 39024552
Metaplastic breast carcinomas (mBrCA) are a highly aggressive subtype of triple-negative breast cancer with histologic evidence of epithelial-to-mesenchymal transition and aberrant differentiation. Inactivation of the tumor suppressor gene cellular communication...
3.
Qin T, Li S, Henry L, Chou E, Cavalcante R, Garb B, et al.
Cancer Res Commun
. 2023 Sep;
3(8):1701-1715.
PMID: 37654626
Significance: This study revealed that the previously observed hypermethylation of HPV(+) HNSCC is due solely to the IMU subtype, illustrating the importance of fine-scale subtype analysis in such a heterogeneous...
4.
Petroff R, Cavalcante R, Colacino J, Goodrich J, Jones T, Lalancette C, et al.
Front Cell Dev Biol
. 2023 Jun;
11:1198148.
PMID: 37384255
The developing epigenome changes rapidly, potentially making it more sensitive to toxicant exposures. DNA modifications, including methylation and hydroxymethylation, are important parts of the epigenome that may be affected by...
5.
Petroff R, Cavalcante R, Langen E, Dolinoy D, Padmanabhan V, Goodrich J
Clin Epigenetics
. 2023 Mar;
15(1):49.
PMID: 36964604
Background: Per- and polyfluoroalkyl substances (PFAS) are chemicals that are resistant to degradation and ubiquitous in our environments. PFAS may impact the developing epigenome, but current human evidence is limited...
6.
Qin T, Lee C, Li S, Cavalcante R, Orchard P, Yao H, et al.
Genome Biol
. 2022 Apr;
23(1):105.
PMID: 35473573
Background: Revealing the gene targets of distal regulatory elements is challenging yet critical for interpreting regulome data. Experiment-derived enhancer-gene links are restricted to a small set of enhancers and/or cell...
7.
Laubach Z, Greenberg J, Turner J, Montgomery T, Pioon M, Sawdy M, et al.
Nat Commun
. 2021 Jul;
12(1):4398.
PMID: 34285226
Studies in rodents and captive primates suggest that the early-life social environment affects future phenotype, potentially through alterations to DNA methylation. Little is known of these associations in wild animals....
8.
Liu S, Wang K, Svoboda L, Rygiel C, Neier K, Jones T, et al.
Environ Epigenet
. 2021 May;
7(1):dvab004.
PMID: 33986952
Di(2-ethylhexyl) phthalate (DEHP) is a type of phthalate plasticizer found in a variety of consumer products and poses a public health concern due to its metabolic and endocrine disruption activities....
9.
Huang S, Tripathi P, Koneva L, Cavalcante R, Craig N, Scruggs A, et al.
Environ Epigenet
. 2021 Mar;
7(1):dvaa022.
PMID: 33692908
Exposure to particulate matter (PM) from ambient air pollution is a well-known risk factor for many lung diseases, but the mechanism(s) for this is not completely understood. Bronchial epithelial cells,...
10.
Liu S, Medeiros M, Fernandez E, Zarins K, Cavalcante R, Qin T, et al.
Clin Epigenetics
. 2020 Nov;
12(1):175.
PMID: 33203436
Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide, with human papillomavirus (HPV)-related HNSCC rising to concerning levels. Extensive clinical, genetic and epigenetic differences...